Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

[Multiple choristoma and a myelolipoma in a Sheltie].

Cubillos CC, Köhler C, Fromme V, Leitner S, Hauber E, Schwede M, Alef M, Kiefer I.

Tierarztl Prax Ausg K Kleintiere Heimtiere. 2018 Jun;46(3):187-194. doi: 10.15654/TPK-170623. Epub 2018 Jun 13. German.

PMID:
29898481
2.

Strong correlation of downregulated genes related to synaptic transmission and mitochondria in post-mortem autism cerebral cortex.

Schwede M, Nagpal S, Gandal MJ, Parikshak NN, Mirnics K, Geschwind DH, Morrow EM.

J Neurodev Disord. 2018 Jun 1;10(1):18. doi: 10.1186/s11689-018-9237-x.

3.

Vascular surgery of aortic thrombosis in a dog using Fogarty maneuver - technical feasibility.

Schwede M, Richter O, Alef M, Theuß T, Loderstedt S.

Clin Case Rep. 2017 Dec 16;6(1):214-219. doi: 10.1002/ccr3.1295. eCollection 2018 Jan.

4.

Mutations in mitochondrial enzyme GPT2 cause metabolic dysfunction and neurological disease with developmental and progressive features.

Ouyang Q, Nakayama T, Baytas O, Davidson SM, Yang C, Schmidt M, Lizarraga SB, Mishra S, Ei-Quessny M, Niaz S, Gul Butt M, Imran Murtaza S, Javed A, Chaudhry HR, Vaughan DJ, Hill RS, Partlow JN, Yoo SY, Lam AT, Nasir R, Al-Saffar M, Barkovich AJ, Schwede M, Nagpal S, Rajab A, DeBerardinis RJ, Housman DE, Mochida GH, Morrow EM.

Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):E5598-607. doi: 10.1073/pnas.1609221113. Epub 2016 Sep 6.

5.

Expansion of the clinical phenotype associated with mutations in activity-dependent neuroprotective protein.

Pescosolido MF, Schwede M, Johnson Harrison A, Schmidt M, Gamsiz ED, Chen WS, Donahue JP, Shur N, Jerskey BA, Phornphutkul C, Morrow EM.

J Med Genet. 2014 Sep;51(9):587-9. doi: 10.1136/jmedgenet-2014-102444. Epub 2014 Jul 23. No abstract available.

6.

Taxonomy of breast cancer based on normal cell phenotype predicts outcome.

Santagata S, Thakkar A, Ergonul A, Wang B, Woo T, Hu R, Harrell JC, McNamara G, Schwede M, Culhane AC, Kindelberger D, Rodig S, Richardson A, Schnitt SJ, Tamimi RM, Ince TA.

J Clin Invest. 2014 Feb;124(2):859-70. doi: 10.1172/JCI70941. Epub 2014 Jan 27.

7.

Compliance and falsification of duty hours: reports from residents and program directors.

Drolet BC, Schwede M, Bishop KD, Fischer SA.

J Grad Med Educ. 2013 Sep;5(3):368-73. doi: 10.4300/JGME-D-12-00375.1. No abstract available.

8.

Gene expression signature of normal cell-of-origin predicts ovarian tumor outcomes.

Merritt MA, Bentink S, Schwede M, Iwanicki MP, Quackenbush J, Woo T, Agoston ES, Reinhardt F, Crum CP, Berkowitz RS, Mok SC, Witt AE, Jones MA, Wang B, Ince TA.

PLoS One. 2013 Nov 26;8(11):e80314. doi: 10.1371/journal.pone.0080314. eCollection 2013.

9.

Stem cell-like gene expression in ovarian cancer predicts type II subtype and prognosis.

Schwede M, Spentzos D, Bentink S, Hofmann O, Haibe-Kains B, Harrington D, Quackenbush J, Culhane AC.

PLoS One. 2013;8(3):e57799. doi: 10.1371/journal.pone.0057799. Epub 2013 Mar 11.

10.

Genes for endosomal NHE6 and NHE9 are misregulated in autism brains.

Schwede M, Garbett K, Mirnics K, Geschwind DH, Morrow EM.

Mol Psychiatry. 2014 Mar;19(3):277-9. doi: 10.1038/mp.2013.28. Epub 2013 Mar 19. No abstract available.

11.

An unbalanced translocation involving loss of 10q26.2 and gain of 11q25 in a pedigree with autism spectrum disorder and cerebellar juvenile pilocytic astrocytoma.

Minhas HM, Pescosolido MF, Schwede M, Piasecka J, Gaitanis J, Tantravahi U, Morrow EM.

Am J Med Genet A. 2013 Apr;161A(4):787-91. doi: 10.1002/ajmg.a.35841. Epub 2013 Mar 12.

12.

Profiles of genomic instability in high-grade serous ovarian cancer predict treatment outcome.

Wang ZC, Birkbak NJ, Culhane AC, Drapkin R, Fatima A, Tian R, Schwede M, Alsop K, Daniels KE, Piao H, Liu J, Etemadmoghadam D, Miron A, Salvesen HB, Mitchell G, DeFazio A, Quackenbush J, Berkowitz RS, Iglehart JD, Bowtell DD; Australian Ovarian Cancer Study Group, Matulonis UA.

Clin Cancer Res. 2012 Oct 15;18(20):5806-15. doi: 10.1158/1078-0432.CCR-12-0857. Epub 2012 Aug 21.

13.

Therapeutic implications of GIPC1 silencing in cancer.

Chittenden TW, Pak J, Rubio R, Cheng H, Holton K, Prendergast N, Glinskii V, Cai Y, Culhane A, Bentink S, Schwede M, Mar JC, Howe EA, Aryee M, Sultana R, Lanahan AA, Taylor JM, Holmes C, Hahn WC, Zhao JJ, Iglehart JD, Quackenbush J.

PLoS One. 2010 Dec 30;5(12):e15581. doi: 10.1371/journal.pone.0015581.

14.

Effects of established allergen sensitization on immune and airway responses after secondary allergen sensitization.

Blumchen K, Gerhold K, Schwede M, Niggemann B, Avagyan A, Dittrich AM, Wagner B, Breiteneder H, Hamelmann E.

J Allergy Clin Immunol. 2006 Sep;118(3):615-21. Epub 2006 Jul 28.

PMID:
16950279

Supplemental Content

Loading ...
Support Center